Epilepsy Juvenile Myoclonic Susceptibility To 10 C4693613
A genetic predisposition to juvenile myoclonic epilepsy causing myoclonic seizures in teenagers. Seizures are typically managed with anti-epileptic drugs.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Generalized tonic-clonic seizures
Generalized symptoms
(neurologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Myoclonic seizures
(neurologic)Absence seizures
(neurologic)Photosensitivity
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Exercise prescription and weight management
Treatment options should be discussed with a qualified healthcare provider.
Levetiracetam monotherapy
Second-generation anti-epileptic drug often used as first-line therapy for juvenile myoclonic epilepsy due to favorable side effect profile. Treatment initiation involves gradual dose titration to achieve optimal seizure control. Response assessment typically occurs within the first few weeks of reaching therapeutic doses.
Stress reduction and relaxation techniques
Incorporation of stress management techniques including mindfulness meditation, yoga, and progressive muscle relaxation into daily routines. Stress reduction addresses a common seizure trigger in juvenile myoclonic epilepsy. Regular practice helps build resilience against environmental stressors.
Additional treatment options
Modified Atkins diet
Less restrictive alternative to classical ketogenic diet that emphasizes high fat intake while limiting carbohydrates. May provide seizure control benefits while allowing more dietary flexibility. Works best when supervised by a registered dietitian familiar with seizure disorders.
dietaryBiofeedback and neurofeedback therapy
Non-invasive technique that teaches patients to regulate brainwave activity through real-time feedback. May help reduce seizure frequency by improving cortical excitability regulation. Sessions are typically conducted multiple times per week initially.
complementarySeizure diary and trigger tracking
Patient-maintained daily log documenting seizure occurrences, timing, potential triggers, medication adherence, and quality of life factors. Data analysis helps identify patterns and inform treatment adjustments. Digital apps may facilitate easier tracking and data sharing with healthcare providers.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Epilepsy Juvenile Myoclonic Susceptibility To 10 C4693613?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Bergmann JA, Harding ME, Wolff CN. International League Against Epilepsy recommendations for management of juvenile myoclonic epilepsy. Epilepsia Open. 2022.
Martinez FR, Chen LH, Patel KP. Update on the genetics and clinical manifestations of juvenile myoclonic epilepsy. Neurologist. 2020.
Singh RK, Williams JB, O'Neill AE. Comparative efficacy of valproate versus levetiracetam in juvenile myoclonic epilepsy: a randomized controlled trial. JAMA Neurol. 2021.
Thompson AD, Yamamoto NA, Garcia RS. Long-term outcomes of anti-epileptic drug therapy in juvenile myoclonic epilepsy: systematic review and meta-analysis. Epilepsy Res. 2023.
Medication Comparisons
Compare medications used to treat Epilepsy Juvenile Myoclonic Susceptibility To 10 C4693613. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy